Clinical Trials Browser

Phase 1 × Triple Negative Breast Neoplasms × Trastuzumab × Clear all

NCT01969643 2023-03-07

A Safety Study of SGN-LIV1A in Breast Cancer Patients

Phase 1 Completed

Neoplasm Metastasis, Triple Negative Breast Neoplasms